Managers
ACProducts (acpi) is to acquire Elkay Wood Products Company (EWP), a manufacturer of kitchen and bath cabinetry.
EWP is a renowned manufacturer with an iconic brand portfolio including Medallion, Design-Craft, Yorktowne, Schuler, Medallion at Menards, MasterCraft, and American Cabinetry Collection.
The combined company will represent the most diverse and balanced cabinet company in North America. With an expansive portfolio across both framed and frameless product offerings, the combined company will be a leader in serving the dealer, direct-to-builder, and home centre channels. The combined plant network spans a national footprint with infrastructure to effectively serve cabinet buyers in all
The Riverside Company has signed a definitive agreement to sell its investment in Euromed Botanicals SA (Euromed) to Dermapharm Holding SE.
Barcelona-based Euromed provides standardised herbal extracts and natural active substances for the pharmaceutical, dietary supplement and cosmetic industries. The transaction is expected to close in the next few months upon receipt of antitrust approval.
Riverside invested in the company back in 2015. Euromed processes more than 5,000 tons of raw materials every year to produce high-quality extracts to meet the needs of more than 300 customers in 35 countries worldwide.
“Euromed’s already-premier brand and quality product
Oxane Partners, a technology-driven solutions provider to the alternative investments industry, has signed long term engagements with four New York based firms in the last six months, strengthening its foothold in the US market.
The new clientele, all credit-focussed investment firms with interests in real estate, specialty finance and alternative lending would be leveraging Oxane’s portfolio management, reporting and analytics solutions.
The common theme, across the newly added clients, was the challenge in managing the growing volume of unstructured data and to consolidate, standardise, process and analyse it for efficient portfolio management. The firms were saddled with increasing complexity
DIP Capital’s Disruption Investment Platform (DIP) Fund I has invested GBP1.5 million in wejo, a leading UK technology company which collates data from connected vehicles.
DIP Capital was established in February 2018 and focuses on investing in disruptive businesses. Founded and led by Riccardo Cirillo, DIP has a first fund of EUR40 million for deployment globally and is sponsored by Platina Partners, an independent European investment firm focusing on renewable energy and private equity.
DIP’s investment in wejo was part of a larger round that also included the participation of the majority of existing wejo investors. The investment will
FundRock Management Company (FundRock) has completed the acquisition of SEB Fund Services (SEB FS) from Skandinaviska Enskilda Banken AB (publ) (SEB).
The deal was first announced on 22 May and has concluded following regulatory approval from the Commission de Surveillance du Secteur Financier (CSSF).
SEB FS is offering third party management company services to Nordic asset managers with Luxembourg-based investment funds. The business in its entirety, including some 20 employees, is as of today transferred to FundRock.
“This move is part of our five year plan and provides a strong foundation to reach our goal of becoming
Audax Private Equity (Audax) and LLR Partners (LLR), in partnership with management, have completed the sale of Numotion to AEA Investors (AEA) and Numotion management.
Headquartered in Brentwood, TN, Numotion is a provider of Complex Rehab Technology (CRT), improving the lives of people with disabilities by enabling them to actively participate in everyday life. CRT is medically necessary, individually configured mobility products and services, including manual and power wheelchairs, designed to meet the unique medical and functional needs of individuals with significant disabilities and medical conditions to provide them with greater independence. Numotion serves over 250,000 customers across 140 locations
Camel-IDS, a VUB spin-off company developing cancer-targeted radio-pharmaceuticals, has secured EUR37 million in a Series A investment round led by V-Bio Ventures (Belgium) and Gimv (Belgium), joined by the co- lead investors HealthCap (Sweden), Novo Seeds (Denmark), Pontifax (Israel) and BioMedPartners (Switzerland). Existing investors also participated.
The proceeds will enable Camel-IDS to run a phase Ib/II trial with its lead program CAM-H2 targeting HER2-positive brain metastatic breast cancer, while further progressing and broadening its preclinical pipeline. 
 

Breast cancer patients with tumours that over-express HER2, a growth-promoting protein, can benefit from effective targeted treatments today, yet have a poor prognosis when
Jet Investment has closed its second fund Jet 2 with CZK4 billion in capital commitments from making it the largest private equity fund in the Czech Republic open to a broader range of investors.
The investment horizon of the fund is set from eight to ten years, with the funds raised set to be invested in private companies, particularly in the industrial sector in the Central and Eastern European region.
Over 160 private investors, family investment companies and financial institutions such as banks, insurance companies and international asset managers made commitments to the fund. Jet Investment partners have committed
NOXXON Pharma, a biotechnology company focussed on improving cancer treatments by targeting the tumour microenvironment (TME), has secured an equity capital raise totalling EUR6.2 million, including USD5 million committed by lead investor, Acuitas Capital, LLC, a US based family office.
This equity capital raise meets the criteria to end YA II PN’s (Yorkville) ability to invest in NOXXON via the variable rate equity vehicle without the consent of NOXXON. Additionally, NOXXON has contractually committed not to use Yorkville or any other variable rate vehicles for two years, by which time the ability to pull tranches from the Yorkville vehicle will
Swander Pace Capital, a private equity firm specialising in investments in consumer products companies, has acquired Bäckerhaus Veit, a producer of artisan, European-style breads, rolls, buns and soft pretzel products for top-tier retail and foodservice customers across North America.
Founded in 1987 by award-winning entrepreneur and CEO Sabine Veit, Bäckerhaus Veit draws on more than 90 years of family heritage in the baking industry, dating back to Veit’s family roots in the Stuttgart region of Germany.
Under Veit’s leadership, the company has grown from serving a handful of Toronto-area retail locations to becoming North America’s signature bakery of the
Events
12 November, 2026 – 8:00 am
12 November, 2026 – 5:00 pm
